Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial)
Introduction Just under half of patients with obstructive sleep apnoea (OSA) also have gastro-oesophageal reflux disease (GORD). These conditions appear to be inter-related and continual positive airway pressure (CPAP) therapy, the gold standard treatment for OSA to prevent airway collapse, has been...
Հիմնական հեղինակներ: | , , , , , , , , , , , , , |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
BMJ Publishing Group
2023-08-01
|
Շարք: | BMJ Open |
Առցանց հասանելիություն: | https://bmjopen.bmj.com/content/13/8/e076661.full |